Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia

Summary

The combination of clofarabine and cytarabine is an effective and reasonably well-tolerated treatment regimen in patients with either relapsed/refractory or newly diagnosed AML. For this prospective study, we propose the use of clofarabine and cytarabine for second course induction therapy for patients with persistent AML after treatment with an anthracycline and cytarabine.

Timeline

Start

2013-10

Primary completion

2015-03

Completion

2015-03

Drugs

Indications